Skip to content

AVALO THERAPEUTICS, INC.: 10-Q filed 2019-11-14

What AVALO THERAPEUTICS, INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 41 published measures, 102 facts as tagged in accession 0001628280-19-014207.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001628280-19-014207 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AVALO THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-3057,193,864USD
At 2018-12-3170,250,721USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-3038,972,590USD
At 2018-12-3149,342,973USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-3018,221,274USD
At 2019-06-3017,696,259USD
At 2018-12-3120,907,748USD
At 2018-09-3019,507,905USD
At 2018-06-3019,219,416USD
At 2017-12-3127,859,608USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-305,250,651USD
At 2018-12-3110,646,301USD
At 2018-09-306,838,353USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-4,016,454USD92
2019-01-01 to 2019-09-30-17,693,601USD273
2018-07-01 to 2018-09-30-24,603,575USD92
2018-01-01 to 2018-09-30-34,493,895USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-17,453,929USD273
2018-01-01 to 2018-09-30-1,152,446USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-30262,011USD273
2018-01-01 to 2018-09-3065,057USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-07-01 to 2019-09-305,613,276USD92
2019-01-01 to 2019-09-3015,474,123USD273
2018-07-01 to 2018-09-304,074,786USD92
2018-01-01 to 2018-09-3013,342,699USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-3012,423,994USD273
2018-01-01 to 2018-09-304,237,244USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-262,011USD273
2018-01-01 to 2018-09-301,364,818USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-115,911,671USD
At 2018-12-31-98,218,070USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-07-01 to 2019-09-30115,651USD92
2019-01-01 to 2019-09-30348,427USD273
2018-07-01 to 2018-09-3052,412USD92
2018-01-01 to 2018-09-3092,076USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-301,496,431USD
At 2018-12-31586,512USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,942,196USD273
2018-01-01 to 2018-09-301,796,387USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-3,715,356USD92
2019-01-01 to 2019-09-30-16,713,973USD273
2018-07-01 to 2018-09-30-24,313,315USD92
2018-01-01 to 2018-09-30-33,820,481USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-3012,589,126USD
At 2018-12-3121,931,893USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-3017,262,222USD
At 2018-12-3126,216,579USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-30826,472USD
At 2018-12-311,446,141USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2019-09-3016,411,123USD
At 2018-12-3116,411,123USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-309,328,632USD92
2019-01-01 to 2019-09-3032,188,096USD273
2018-07-01 to 2018-09-3028,388,101USD92
2018-01-01 to 2018-09-3047,163,180USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-30402,267USD
At 2018-12-311,110,780USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3044,106,794shares
At 2018-12-3140,804,189shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-09-305,454,810USD
At 2018-12-3110,746,756USD
At 2018-09-307,055,115USD
At 2017-12-312,605,499USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-30134,085,981USD
At 2018-12-31119,082,157USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-30719,113USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-301,235,754USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2019-09-3026,595,239USD
At 2018-12-3131,239,468USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-09-301,121,367USD
At 2018-12-31385,517USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-301,670,019USD
At 2018-12-311,529,516USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2019-09-3098,061USD
At 2018-12-3169,238USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,679,396USD92
2019-01-01 to 2019-09-307,778,386USD273
2018-07-01 to 2018-09-301,884,293USD92
2018-01-01 to 2018-09-307,833,612USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-01-01 to 2019-09-303,266,313USD273
2018-01-01 to 2018-09-303,333,416USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,037,414USD92
2019-01-01 to 2019-09-303,195,108USD273
2018-07-01 to 2018-09-301,065,398USD92
2018-01-01 to 2018-09-303,315,843USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-185,447USD92
2019-01-01 to 2019-09-30-631,201USD273
2018-07-01 to 2018-09-30-237,848USD92
2018-01-01 to 2018-09-30-581,338USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2019-01-01 to 2019-09-3028,823USD273
2018-01-01 to 2018-09-30-47,994USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-30787,500USD273
2018-01-01 to 2018-09-30262,500USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-09-308,975,960USD273
2018-01-01 to 2018-09-300USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-01-01 to 2019-03-310USD90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,798,216USD273
2018-01-01 to 2018-09-3073,513USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-601,241USD273
2018-01-01 to 2018-09-30226,735USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-619,669USD273
2018-01-01 to 2018-09-30172,243USD273

Inspect the source

Entity
AVALO THERAPEUTICS, INC. / CIK 0001534120
Captured
2026-09-20T09:16:35.394Z
SEC response SHA-256
c27cef5388033067af62e0489a1b2af90f086713b680df0f63e0f63ad2ea1ca3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534120.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))